ArticleMethods in molecular biology (Clifton, N.J.)2025
Mammalian Cell Display with Automated Oligo Design and Library Assembly Allows for Rapid Residue Level Conformational Epitope Mapping.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Precise epitope determination of therapeutic antibodies is of great value as it allows for further comprehension of the mechanism of action, therapeutic responsiveness prediction, avoidance of unwanted cross-reactivity, and vaccine design. Alanine scanning mutagenesis can provide an amino acid level resolution of a precise epitope for conformational epitopes. If the mutated antigen is presented on the surface of cells, high throughput screening is enabled without the need for protein expression and purification. Here we present a combinatorial method for rapid mapping of discontinuous epitopes by mammalian antigen display, facilitated by automated workflows for high throughput cloning and tailored software for antigen analysis and oligonucleotide design.
Indexed as
Identifiers
40593418What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.